Target intelligence / Profile preview

Other human mRNAs with partial complementarity to the SETD8 shRNA guide strand

Molecular classification
Messenger RNA, Other
01

Overview

This term refers to the unintended silencing of various human messenger RNAs (mRNAs) by a short hairpin RNA (shRNA) designed to target the SETD8 gene. SETD8, also known as KMT5A, is a histone methyltransferase that specifically monomethylates histone H4 at lysine 20 (H4K20me1), a modification essential for chromatin condensation, DNA replication, and DNA damage repair (Nishioka et al., 2002; Rice et al., 2002). Off-target effects arise when the shRNA guide strand binds to non-target mRNAs via partial sequence complementarity, primarily through the 2-7 nucleotide "seed" region in the 3' untranslated region (UTR) of the transcript (Lewis et al., 2003; Birmingham et al., 2006). These interactions can lead to mRNA degradation or translational inhibition, resulting in phenotypic changes that are not caused by the loss of SETD8 itself (Jackson et al., 2003). In drug discovery and functional genomics, these off-targets are a significant source of experimental noise and potential toxicity for RNAi-based therapeutics. Identifying and mitigating these effects is crucial for ensuring the specificity of gene knockdown and the safety of therapeutic interventions.

Other names
SETD8 shRNA off-targetsRNAi off-target transcriptsSeed-matched off-target mRNAsNon-specific shRNA effects
02

Mechanism of action

RNA interference-mediated degradation or translational inhibition of non-target mRNAs via partial sequence complementarity (Jackson et al., 2003; Birmingham et al., 2006).

03

Biological functions

Gene silencingRNA interferencePost-transcriptional regulation
04

Disease associations

CancerOther
05

Safety considerations

Off-target toxicityFalse positive results in functional genomicsUnintended gene silencingSaturation of the RNAi machinery
06

Interacting drugs

SETD8 shRNA
07

Biomarkers

RNA-seqTranscriptome profilingQuantitative PCR (qPCR)

Beyond the preview

Go deeper on Other human mRNAs with partial complementarity to the SETD8 shRNA guide strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other human mRNAs with partial complementarity to the SETD8 shRNA guide strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call